CHF 488k · Pre-Seed · Healthtech · Davos, Switzerland
avaisor, a Davos medtech building a platform for surgical knowledge transfer, has secured CHF 488k in pre-seed commitments from a syndicate of more than 15 surgeons, a Singapore family office and a Swiss business angel. According to the company-supplied announcement, the capital will support product development, early-user validation and preparation for international scaling.
Clinical reasoning becomes the product
Surgical videos show a procedure, but they rarely capture why an experienced clinician chose one approach, rejected another or weighed a particular risk. avaisor asks surgeons to contribute that reasoning and structures it into interactive knowledge avatars that other clinicians can explore. The company is in early access with a small group of surgeons and medtech partners.
That creates two potential customer routes around the same knowledge base. Surgeons and trainees can use it as an on-demand extension of peer teaching, while medtech companies can connect device education to the reasoning of clinicians who use those products. The commercial advantage is not simply more content. It is making specialist judgement searchable and reusable without requiring the expert to teach every session in person.
Expert backing can shorten the trust cycle
The investor group matters because the same clinical community that supplies capital can also test the product, contribute expertise and introduce it to peers. In medical education, that route can be more valuable than broad user acquisition: adoption depends on whether clinicians recognise the expert, trust the context and can trace advice back to a real decision framework.
The next test is validation. avaisor says contributors retain control over their knowledge and that the platform is GDPR compliant, but a useful product must also preserve nuance as cases and techniques vary. The funding gives the company room to prove that its structured avatars can support learning without flattening clinical judgement, and that medtech customers will pay for better product education rather than another static content library.
